Elevance Health, Inc.

For the period ended Mar 31, 2026. Filed Apr 22, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed Apr 22, 2026

ELV$429.65+2.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets as of (Unaudited) and December 31,

Consolidated Balance Sheets

	March 31,2026	December 31,2025
(Unaudited)
(In millions, except share and per share data)
Assets
Current assets:
Cash and cash equivalents	$9,657	$9,491
Fixed maturity securities (amortized cost of $26,177 and $25,773; allowance for credit losses of $55 and $21)	25,905	25,884
Equity securities	1,511	740
Premium receivables, net	11,525	10,073
Self-funded receivables, net	5,098	5,162
Other receivables	6,167	6,307
Other current assets	7,169	5,344
Total current assets	67,032	63,001
Long-term investments:
Fixed maturity securities (amortized cost of $1,121 and $1,116; allowance for credit losses of $0 and $0)	1,114	1,121
Other invested assets	11,009	10,839
Property and equipment, net	4,657	4,679
Goodwill	28,340	28,344
Other intangible assets	11,093	11,200
Other noncurrent assets	2,582	2,310
Total assets	$125,827	$121,494
Liabilities and equity
Liabilities
Current liabilities:
Medical claims payable	$18,425	$17,084
Other policyholder liabilities	3,857	3,632
Unearned income	1,759	1,493
Accounts payable and accrued expenses	6,209	7,322
Short-term borrowings	724	150
Current portion of long-term debt	350	1,099
Other current liabilities	13,985	10,255
Total current liabilities	45,309	41,035
Long-term debt, less current portion	30,768	30,797
Deferred tax liabilities, net	1,786	2,110
Other noncurrent liabilities	3,922	3,526
Total liabilities	81,785	77,468
Shareholders’ equity
Preferred stock, without par value, shares authorized – 100,000,000; shares issued and outstanding – none	—	—
Common stock, par value $0.01, shares authorized – 900,000,000; shares issued and outstanding – 217,368,494 and 220,723,898	2	2
Additional paid-in capital	8,845	8,938
Retained earnings	35,796	35,393
Accumulated other comprehensive loss	(741)	(451)
Total shareholders’ equity	43,902	43,882
Noncontrolling interests	140	144
Total equity	44,042	44,026
Total liabilities and equity	$125,827	$121,494

-2-

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.